Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-17,000
Closed -$409K 557
2025
Q3
$409K Hold
17,000
0.02% 431
2025
Q2
$331K Hold
17,000
0.02% 475
2025
Q1
$219K Buy
+17,000
New +$273K 0.01% 504
2020
Q1
Sell
-15,000
Closed -$319K 366
2019
Q4
$319K Hold
15,000
0.03% 293
2019
Q3
$344K Hold
15,000
0.04% 271
2019
Q2
$364K Buy
+15,000
New +$309K 0.04% 276
2018
Q1
Sell
-2,763
Closed -$217K 379
2017
Q4
$217K Hold
2,763
0.02% 316
2017
Q3
$232K Buy
+2,763
New +$196K 0.03% 299
2017
Q2
Sell
-2,763
Closed -$201K 363
2017
Q1
$201K Buy
+2,763
New +$182K 0.03% 306

Other funds holding ADNT

RBF Capital's ADNT Position: Q4 2025 in Review

RBF Capital sold out of Adient (ADNT) in Q4 2025, closing a stake of 17,000 shares — an estimated $409K sold.

RBF Capital first reported a position in ADNT in Q1 2017 and held it in 9 quarters. The position peaked at $409K in Q3 2025. 291 funds tracked by Wall St. Rank hold ADNT as of Q4 2025.

  • RBF Capital reported no remaining Adient position as of Q4 2025 after selling out during the quarter.
  • RBF Capital sold 17,000 Adient shares in Q4 2025, an estimated $409K.
  • RBF Capital first reported a position in Adient in Q1 2017 and held it in 9 quarters.
  • RBF Capital's Adient position peaked at $409K in Q3 2025.
  • 291 funds tracked by Wall St. Rank held Adient as of Q4 2025.

Based on RBF Capital's 13F filing for Q4 2025, filed 17 Feb 2026.